Works (2)

Updated: July 5th, 2023 15:34

2020 review

Polymeric Biomaterial Scaffolds for Tumoricidal Stem Cell Glioblastoma Therapy

[Review of ]. ACS BIOMATERIALS SCIENCE & ENGINEERING, 6(7), 3762–3777.

author keywords: Hydrogels; microcapsules; electrospinning; local drug delivery; surgical resection
MeSH headings : Biocompatible Materials; Brain Neoplasms / therapy; Glioblastoma / therapy; Humans; Neoplasm Recurrence, Local; Stem Cells
Source: Web Of Science
Added: August 10, 2020

2018 journal article

Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection

MOLECULAR PHARMACEUTICS, 15(3), 1309–1318.

author keywords: Ace-DEX; poly lactide (PLA); polyanhidride; carmustine; drug delivery; nanofiber
MeSH headings : Acetals / chemistry; Animals; Antibiotics, Antineoplastic / administration & dosage; Antibiotics, Antineoplastic / pharmacokinetics; Brain / pathology; Brain / surgery; Brain Neoplasms / drug therapy; Brain Neoplasms / pathology; Brain Neoplasms / surgery; Cell Line, Tumor; Cell Survival / drug effects; Delayed-Action Preparations / administration & dosage; Delayed-Action Preparations / pharmacokinetics; Dextrans / chemistry; Disease Progression; Doxorubicin / administration & dosage; Doxorubicin / pharmacokinetics; Drug Delivery Systems / methods; Drug Liberation; Glioblastoma / drug therapy; Glioblastoma / pathology; Glioblastoma / surgery; Humans; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Recurrence, Local / prevention & control; Treatment Outcome; Xenograft Model Antitumor Assays
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.